Aggressive HER2-Positive Gastric Cancer in a Young Patient, Refractory in Trastuzumab and Progressive with Trastuzumab-Emtansine Treatment
Gastric cancer remains a major global health problem. Gastric cancer is the fifth most frequently diagnosed cancer and the third leading cause of cancer-related deaths in the world. The prognosis of the disease is poor because it is often diagnosed at later stages, especially at HER2-positive. Most...
| الحاوية / القاعدة: | International Journal of Biomedicine |
|---|---|
| المؤلفون الرئيسيون: | , , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
International Medical Research and Development Corporation
2024-03-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | http://www.ijbm.org/articles/i53/ijbm_14(1)_cr8.pdf |